Influence of plasma lipoproteins on the fibrinolytic activity.
D000818:Animals; D000933:Antifibrinolytic Agents; D001161:Arteriosclerosis / Q000097:blood; D002021:Buffers; D002364:Caseins; D002417:Cattle; D011232:Chemical Precipitation; D002914:Chylomicrons / Q000097:blood; D003911:Dextrans; D005260:Female; D005340:Fibrinogen; D005341:Fibrinolysin; D005342:Fibrinolysis; D006493:Heparin; D006801:Humans; D008064:Lipidoses / Q000097:blood; D008074:Lipoproteins / Q000097:blood* / Q000494:pharmacology; D008297:Male; D049590:Postpartum Period; D011247:Pregnancy; D013552:Swine; D013696:Temperature
D000933:Antifibrinolytic Agents; D002021:Buffers; D002364:Caseins; D002914:Chylomicrons; D003911:Dextrans; D008074:Lipoproteins; D005340:Fibrinogen; D006493:Heparin; D005341:Fibrinolysin